Ubs Asset Management Americas Inc Relay Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $277 Billion
- Q1 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 557,296 shares of RLAY stock, worth $3.61 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
557,296
Previous 841,866
33.8%
Holding current value
$3.61 Million
Previous $9.27 Million
50.1%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RLAY
# of Institutions
187Shares Held
127MCall Options Held
4.2KPut Options Held
1.7K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$181 Million2.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$76.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.8MShares$63.5 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY7.42MShares$48.1 Million4.98% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.88MShares$44.6 Million0.01% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $779M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...